BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17999418)

  • 1. Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.
    Jin Z; Mori Y; Hamilton JP; Olaru A; Sato F; Yang J; Ito T; Kan T; Agarwal R; Meltzer SJ
    Cancer; 2008 Jan; 112(1):43-9. PubMed ID: 17999418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.
    Jin Z; Wang L; Cao Z; Cheng Y; Gao Y; Feng X; Chen S; Yu H; Wu W; Zhao Z; Dong M; Zhang X; Liu J; Fan X; Mori Y; Meltzer SJ
    BMC Cancer; 2014 May; 14():345. PubMed ID: 24885118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
    Jin Z; Cheng Y; Olaru A; Kan T; Yang J; Paun B; Ito T; Hamilton JP; David S; Agarwal R; Selaru FM; Sato F; Abraham JM; Beer DG; Mori Y; Shimada Y; Meltzer SJ
    Int J Cancer; 2008 Nov; 123(10):2331-6. PubMed ID: 18729198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
    Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
    Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
    Jin Z; Mori Y; Yang J; Sato F; Ito T; Cheng Y; Paun B; Hamilton JP; Kan T; Olaru A; David S; Agarwal R; Abraham JM; Beer D; Montgomery E; Meltzer SJ
    Oncogene; 2007 Sep; 26(43):6332-40. PubMed ID: 17452981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
    Jin Z; Zhao Z; Cheng Y; Dong M; Zhang X; Wang L; Fan X; Feng X; Mori Y; Meltzer SJ
    Cancer; 2013 Oct; 119(20):3604-9. PubMed ID: 23893879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
    Jin Z; Olaru A; Yang J; Sato F; Cheng Y; Kan T; Mori Y; Mantzur C; Paun B; Hamilton JP; Ito T; Wang S; David S; Agarwal R; Beer DG; Abraham JM; Meltzer SJ
    Clin Cancer Res; 2007 Nov; 13(21):6293-300. PubMed ID: 17975140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
    Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
    Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
    Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ
    Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.
    Jin Z; Feng X; Jian Q; Cheng Y; Gao Y; Zhang X; Wang L; Zhang Y; Huang W; Fan X; Chen S; Yu H; Zhao Z; Dong M; Liu J; Mori Y; Meltzer SJ
    Anticancer Res; 2013 Nov; 33(11):5199-203. PubMed ID: 24222170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of somatostatin in gastric cancer.
    Jackson K; Soutto M; Peng D; Hu T; Marshal D; El-Rifai W
    Dig Dis Sci; 2011 Jan; 56(1):125-30. PubMed ID: 20927589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma.
    Meng XY; Zhu ST; Zong Y; Wang YJ; Li P; Zhang ST
    Dis Esophagus; 2011 Aug; 24(6):444-9. PubMed ID: 21166741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.
    Dong SW; Zhang P; Liu YM; Cui YT; Wang S; Liang SJ; He Z; Sun P; Wang YG
    World J Gastroenterol; 2012 Feb; 18(6):576-82. PubMed ID: 22363126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.